Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
Ascentage Pharma Group International stock last closed at $33.42, up 2.14% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Ascentage Pharma Group International stock is currently +96.59% from its 52-week low of $17.00, and -31.02% from its 52-week high of $48.45.
As of Oct 31, 2025, there are 349M AAPG shares outstanding. The market value of AAPG is $2.92B. In the last 24 hours, 3900 AAPG shares were traded.
You will need a brokerage account to access the NASDAQ market and buy AAPG shares.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, it's time to fill out some personal information so you can buy AAPG stock today.
Now that you've filled out your info on our top ranked stock market app, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your brokerage account.
Once you have decided on the best place to buy Ascentage Pharma Group International stock, it's critical to evaluate their stock before you invest, so you can understand the risk and upside.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on AAPG's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge AAPG's true value.
Using relative valuations metrics:
You can access additional valuation research on AAPG's stock here.
You can dive deeper into what analysts are saying on the Ascentage Pharma Group International stock forecast page.
Last year, AAPG revenue was $54.40M. Over the past 1 years, AAPG's revenue has gone up by -56.32% per year. This was slower than the Biotechnology industry average of 68.21%.
Find out more about AAPG's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at AAPG have not bought or sold any shares.
Dig into more about who owns AAPG shares here.
No, Ascentage Pharma Group International doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary order types:
Press the Open Trade button and eToro will place the order.
If you need more help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in AAPG, you'll want to stay up-to-date on your investment.
Make a watchlist to track the most important metrics related to your AAPG stock.
To summarize, here are the 6 steps to buy stock in Ascentage Pharma Group International:
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Ascentage Pharma Group International, hit the button below to create your watchlist.